1.
Orbit
; 27(4): 329-30, 2008.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18716976
RESUMO
Erlotinib (Tarceva, Roche) is a chemotherapeutic agent used in the management of advanced non-small cell lung cancer and other malignancies. We present the case of a patient who developed excessive eyelash growth, called trichomegaly, a rare ocular side effect of this drug.